These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1196433)
1. Methotrexate and folic acid effect in normal and sarcoma 180 bearing mice. Motycka K; Balcarová A Neoplasma; 1975; 22(5):507-18. PubMed ID: 1196433 [TBL] [Abstract][Full Text] [Related]
2. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models. Sirotnak FM; Moccio DM; Dorick DM Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375 [TBL] [Abstract][Full Text] [Related]
3. Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates. Motycka K; Slavík K; Balcarová A; Spacek P; Kubín M Czech Med; 1981; 4(1-2):14-24. PubMed ID: 6973453 [TBL] [Abstract][Full Text] [Related]
4. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative. Motycka K; Slavík K; Dyr JE; Balcarová A; Vodrázka Z Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of hydroxythiamine and methotrexate immobilized on monocarboxycellulose. Zimatkina T; Yurkshtovich T; Zimatkin S; Kaputsky F Pol J Pharmacol; 1996; 48(2):163-9. PubMed ID: 9112646 [TBL] [Abstract][Full Text] [Related]
6. Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer. Lobo ED; Balthasar JP J Pharm Sci; 2005 Sep; 94(9):1957-64. PubMed ID: 16052545 [TBL] [Abstract][Full Text] [Related]
7. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative. Bures L; Motycka K; Bostík J; Slavík K; Jirásek A Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803 [TBL] [Abstract][Full Text] [Related]
8. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing. Bures L; Bostík J; Motycka K; Spundová M; Rehák L Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341 [TBL] [Abstract][Full Text] [Related]
9. Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil. Bertino JR; Sawicki WL; Lindquist CA; Gupta VS Cancer Res; 1977 Jan; 37(1):327-8. PubMed ID: 830420 [TBL] [Abstract][Full Text] [Related]
10. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action. Rumberger BG; Barrueco JR; Sirotnak FM Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741 [TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors. Schmitt DA; Kisanuki K; Kimura S; Oka K; Pollard RB; Maeda H; Suzuki F Anticancer Res; 1992; 12(6B):2219-24. PubMed ID: 1295469 [TBL] [Abstract][Full Text] [Related]
12. Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models. Sirotnak FM; Schmid FA; Otter GM; Piper JR; Montgomery JA Cancer Res; 1988 Oct; 48(20):5686-91. PubMed ID: 3167828 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid. Alati T; Worzalla JF; Shih C; Bewley JR; Lewis S; Moran RG; Grindey GB Cancer Res; 1996 May; 56(10):2331-5. PubMed ID: 8625328 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid. Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071 [TBL] [Abstract][Full Text] [Related]
15. Distribution and pharmacokinetics of methotrexate in localized chemotherapy of solid Gardner's lymphosarcoma. Slavíková V; Motycka K; Slavík K; Spacek P; Cihar R; Balcarová A Neoplasma; 1978; 25(2):211-6. PubMed ID: 580447 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance. Sirotnak FM; Poser RE; Barrueco JR Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533 [TBL] [Abstract][Full Text] [Related]
17. Effect of methotrexate and folinic acid on skeletal growth in mice. Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796 [TBL] [Abstract][Full Text] [Related]
18. Effect of macrophage activation on plasma disposition of niosomal 3H-methotrexate in sarcoma-180 bearing mice. Chandraprakash KS; Udupa N; Umadevi P; Pillai GK J Drug Target; 1993; 1(2):143-5. PubMed ID: 8069552 [TBL] [Abstract][Full Text] [Related]
19. Lectin derivatives of methotrexate and chlorambucil as chemotherapeutic agents. Lin JY; Li JS; Tung TC J Natl Cancer Inst; 1981 Mar; 66(3):523-8. PubMed ID: 6937708 [TBL] [Abstract][Full Text] [Related]
20. Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma. Motycka K; Dyr JE; Macáková A; Slavík K Neoplasma; 1982; 29(2):197-204. PubMed ID: 6896744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]